RhD Antibodies

Santa Cruz Biotechnology features a diverse variety of RhD Antibodies for the detection and analysis of RhD protein, a critical component of the Rh blood group system. RhD Antibodies are compatible with western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). RhD protein plays a significant role in determining an individual's Rh blood type, which is essential for safe blood transfusions and pregnancy management. Understanding the function and expression of RhD protein is crucial for studying hemolytic disease of the newborn and other blood-related disorders. RhD monoclonal antibodies enable precise investigation of the Rh blood group system and its implications in clinical settings. Researchers can effectively analyze RhD protein expression patterns across different cell types and tissues. Advanced research in hematology and transfusion medicine continues to reveal new insights about RhD protein's role in blood type determination and immune responses. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of blood group systems and improving patient care.